Product
Dengue virus 3 Live Virus Human Challenge
1 clinical trial
1 indication
Indication
DengueClinical trial
Phase One, Open Label, Homologous Reinfection With Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) or Dengue-3-Virus-Live Virus Human Challenge (DENV-3-LVHC) Virus StrainsStatus: Active (not recruiting), Estimated PCD: 2024-09-01